[go: up one dir, main page]

WO2004058150A3 - Anti-infectives - Google Patents

Anti-infectives Download PDF

Info

Publication number
WO2004058150A3
WO2004058150A3 PCT/US2003/040133 US0340133W WO2004058150A3 WO 2004058150 A3 WO2004058150 A3 WO 2004058150A3 US 0340133 W US0340133 W US 0340133W WO 2004058150 A3 WO2004058150 A3 WO 2004058150A3
Authority
WO
WIPO (PCT)
Prior art keywords
infectives
disclosed
formula
making
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2003/040133
Other languages
French (fr)
Other versions
WO2004058150A2 (en
Inventor
Duke M Fitch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Priority to AU2003297235A priority Critical patent/AU2003297235A1/en
Publication of WO2004058150A2 publication Critical patent/WO2004058150A2/en
Anticipated expiration legal-status Critical
Publication of WO2004058150A3 publication Critical patent/WO2004058150A3/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Compounds useful as HCV anti-infectives having the formula (I) wherein the formula variables are as defined herein, are disclosed. Also disclosed are methods of making and using the same.
PCT/US2003/040133 2002-12-17 2003-12-11 Anti-infectives Ceased WO2004058150A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003297235A AU2003297235A1 (en) 2002-12-17 2003-12-11 Anti-infectives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43422702P 2002-12-17 2002-12-17
US60/434,227 2002-12-17

Publications (2)

Publication Number Publication Date
WO2004058150A2 WO2004058150A2 (en) 2004-07-15
WO2004058150A3 true WO2004058150A3 (en) 2006-03-30

Family

ID=32682012

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/040133 Ceased WO2004058150A2 (en) 2002-12-17 2003-12-11 Anti-infectives

Country Status (2)

Country Link
AU (1) AU2003297235A1 (en)
WO (1) WO2004058150A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7517876B2 (en) 2005-02-25 2009-04-14 Abbott Laboratories Anti-infective agents

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7902203B2 (en) * 2002-11-01 2011-03-08 Abbott Laboratories, Inc. Anti-infective agents
US7378414B2 (en) 2003-08-25 2008-05-27 Abbott Laboratories Anti-infective agents
JP4624419B2 (en) 2004-08-23 2011-02-02 エフ．ホフマン−ラ ロシュ アーゲー Antiviral heterocyclic compounds
RU2388748C2 (en) 2004-12-21 2010-05-10 Ф. Хоффманн-Ля Рош Аг Tetralin and indane derivatives and use thereof as 5-ht antagonists
JP2008540370A (en) 2005-05-04 2008-11-20 エフ．ホフマン−ラ ロシュ アーゲー Heterocyclic antiviral compounds
ES2359735T3 (en) 2005-11-03 2011-05-26 F. Hoffmann-La Roche Ag ARYLSULPHONYL CHROMANES AS 5-HT6 INHIBITORS.
WO2007093541A1 (en) 2006-02-17 2007-08-23 F. Hoffmann-La Roche Ag Heterocyclic antiviral compounds
KR101066306B1 (en) 2006-06-20 2011-09-20 에프. 호프만-라 로슈 아게 Tetralin and indene derivatives and uses thereof
AU2007263076A1 (en) 2006-06-20 2007-12-27 F. Hoffmann-La Roche Ag Arylsulfonyl naphthalene derivatives and uses thereof
BRPI0713502A2 (en) 2006-06-20 2012-03-13 F. Hoffmann-La Roche Ag arylsulfonamidyl tetraline derivatives and uses of these
CN101979397B (en) 2006-10-10 2013-11-06 美迪维尔公司 HCV nucleoside inhibitor
AU2010220374A1 (en) 2009-03-06 2011-09-01 F. Hoffmann-La Roche Ag Heterocyclic antiviral compounds
KR20120011880A (en) 2009-04-25 2012-02-08 에프. 호프만-라 로슈 아게 Heterocyclic antiviral compounds
WO2010149598A2 (en) 2009-06-24 2010-12-29 F. Hoffmann-La Roche Ag Heterocyclic antiviral compound
WO2011033045A1 (en) 2009-09-21 2011-03-24 F. Hoffmann-La Roche Ag Heterocyclic antiviral compounds
JP2013511489A (en) 2009-11-21 2013-04-04 エフ．ホフマン−ラ ロシュ アーゲー Heterocyclic antiviral compounds

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHOO Q L ET AL: "ISOLATION OF A CDNA CLONE DERIVED FROM A BLOOD-BORNE NON-A, NON-B VIRAL HEPATITIS GENOME.", SCIENCE., vol. 244, 1989, pages 359 - 362, XP001093889 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7517876B2 (en) 2005-02-25 2009-04-14 Abbott Laboratories Anti-infective agents

Also Published As

Publication number Publication date
WO2004058150A2 (en) 2004-07-15
AU2003297235A1 (en) 2004-07-22
AU2003297235A8 (en) 2004-07-22

Similar Documents

Publication Publication Date Title
MXPA03011329A (en) Novel anti-infectives.
WO2003059356A3 (en) Novel anti-infectives
WO2004058150A3 (en) Anti-infectives
WO2004052313A3 (en) Anti-infectives
WO2004018451A8 (en) Pyridazinone-derivatives as pde4 inhibitors
WO2003035617A3 (en) Derivatives of uk-2a
WO2004018449A8 (en) Piperidine-derivatives as pde4 inhibitors
WO2005021497A3 (en) Tethered dimers and trimers of 1,4-diphenylazetidn-2-ones
WO2005030791A3 (en) Isoquinolinone potassium channel inhibitors
WO1999064047A8 (en) Novel antiviral compounds
AU2003222544A1 (en) Homing process
AU2003262747A1 (en) Compounds, compositions, and methods
AU2003265242A1 (en) Compounds, compositions, and methods
WO2003037262A3 (en) Novel anit-infectives
AU2003270015A1 (en) Compounds, compositions, and methods
WO2005030129A3 (en) Quinoline potassium channel inhibitors
WO2005046578A3 (en) Isoquinolinone potassium channel inhibitors
IL158485A (en) Spiropyrazole compounds
WO2005030130A3 (en) Isoquinoline potassium channel inhibitors
EP1283235A3 (en) Composition, method of making, and method of using adhesive composition
AU2003288023A1 (en) Process for the manufacture of 1,2-epoxy-3-chloropropane
AU2003281694A1 (en) 6,11-4-carbon bridged ketolides
AU2003277079A1 (en) Compounds, compositions, and methods
WO2004052312A3 (en) Anti-infectives
AU2001292320A1 (en) Benzylamine compound, process for producing the same, and intermediate therefor

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AU BA BB BR BZ CA CN CO CR CU DM DZ EC EG GD GE HR ID IL IN IS JP KP KR LC LK LR LT LV MA MG MK MN MX NO NZ OM PH PL RO SC SG TN TT UA US UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP